Following over a year’s delay due to the COVID-19 pandemic, the IMAGiNe Study is finally back on track! The IMAGiNe Study (Immunoglobulin M(IgM)-Anti-myelin-associated-glycoprotein (MAG) Peripheral Neuropathy Study) is a research program that aims to create a standardized database and biobank to be used for the research and analysis of Anti-MAG peripheral neuropathy. The goal is to be able to […]
The Foundation for Peripheral Neuropathy (FPN) is pleased to welcome the University of Michigan as a new site for patient enrollments into the Peripheral Neuropathy Research Registry. In this article, FPN’s Executive Director interviews the newest researcher to join this special team, Dr. Amro Stino, and why this new partnership will be fruitful for the […]
Read More… from FPN Welcomes the University of Michigan and Dr. Amro Stino
Exercise to Help Patients with Idiopathic Neuropathy Research has consistently demonstrated that regular exercise reduces polyneuropathy (PN) symptoms in patients with type 2 diabetes. Patients with prediabetes or metabolic syndrome have also shown to benefit from regular exercise. Exercise has also shown to slow progression of peripheral neuropathy in these patient groups. However, little is […]
Read More… from Can Exercise Help Patients with Idiopathic Peripheral Neuropathy?
Following the Foundation for Peripheral Neuropathy‘s (FPN) recent webinar on current research trends, Lindsay Colbert, FPN’s Executive Director, caught up with the program’s panelists, Dr. Senda Ajroud-Driss, Dr. Ahmet Höke and Dr. Gordon Smith to follow-up on some important questions that the program did not have time to cover. In this “Ask the Expert” series, […]
Read More… from Ask the Expert: Popular Questions from PN Patients
In the Foundation for Peripheral Neuropathy’s March 2019 e-newsletter, Dr. Joseph Breitenstein, a professor of psychology and licensed psychologist at Luther College in Decorah, Iowa, and two of his students, Jimmy Conway and Anna Larson, invited people with peripheral neuropathies to participate in a survey on coping with peripheral neuropathy. The main part of the […]
by Jessica Robinson-Papp MD, MS, FAAN Mount Sinai Medical Center, andSara Dehbashi, MD, Neuromuscular Fellow, Mount Sinai Medical Center Medical marijuana use is becoming more common in the U.S. due to legalization in many states. The U.S. federal government still considers all forms of marijuana illegal, however so far they have mostly not interfered with […]
In a new study from Washington University School of Medicine in St. Louis, scientists have blocked the destruction of nerve axons in mice, a step toward helping patients with various neurodegenerative disorders, including peripheral neuropathy. The findings of this report, originally reported by Julia Evangelou Strait, can be found below. Nerve axons serve as the […]
Read More… from Gene Therapy Blocks Peripheral Nerve Damage in Mice
The Foundation for Peripheral Neuropathy receives many inquiries from patients about stem cell treatments for peripheral neuropathy. An article, ‘Snake Oil’ Stem Cell Clinics Peddle False Hope for High Prices recently appeared in The Medium (www.medium.com) on the rise of stem cell treatments for any number of conditions. Is it a real hope or false […]
Read More… from Stem Cell Treatments: A real hope or false promise?
The Foundation for Peripheral Neuropathy (FPN) is pleased to announce a new partnership to further research on anti-MAG IgM paraprotein-associated peripheral neuropathy. FPN will be partnering with the IMAGiNe study, a global research collaborative focusing on anti-MAG and IgM paraprotein-associated peripheral neuropathy. Thanks to a donation from the Atlantic Philanthropies Director/Employee Designated Gift Fund, FPN […]